For condition: Asthma
Research Trial for Severe Uncontrolled Asthma (94 Weeks)
Study Summary
Recruiting children aged 5 to under 12 with severe uncontrolled asthma, to participate in this clinical research trial. Must have documented treatment with a total daily dose of either medium or high dose inhaled corticosteroids (ICS) for at least 3 months, and documented treatment with at least one additional maintenance asthma controller medication.
Participants will receive investigational treatment (active study drug) or placebo, via subcutaneous injection. Following the treatment period, participants may have the option to take part in the open-label extension period, and receive active study drug. Study treatment and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last up to 94 weeks and involve about 24 visits to the study centre, during that time.
For more information about this trial, please visit ClinicalTrials.gov
